BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2010
View Archived Issues
Daiichi Sankyo claims new ligands of voltage-dependent calcium channel subunit alpha2-delta
Read More
University of Ulsan identifies new anticancer prodrugs
Read More
Phase III panitumumab trial in head and neck cancer does not meet primary endpoint
Read More
NeoStem and Schepens Eye Research Institute enter agreement for retinal diseases
Read More
Ustekinumab yields sustained response in phase II and III trials in plaque psoriasis
Read More
Israeli scientists describe new muscarinic acetylcholine M1 receptor modulators
Read More
Italian researchers present new NS5B inhibitors
Read More
Bristol-Myers Squibb claims new S1P1 receptor agonists
Read More
PregLem inlicenses bentamapimod from Merck Serono for postoperative adhesions and endometriosis
Read More
Abobotulinumtoxin A rapidly reduces glabellar lines in phase III trials
Read More
Cannabinoids show promise in models of inflammation and bone loss
Read More
New clindamycin/tretinoin gel more effective than constituents in treating acne
Read More
SLC40A1 is a marker of breast cancer prognosis
Read More
Onabotulinumtoxin A is safe and efficacious in women with vertical lip columns
Read More
Vyteris reports phase II data on transdermal patch for female infertility
Read More
Agile Therapeutics begins phase III trial of contraceptive patch AG-200-15
Read More
Astex and Multiple Myeloma Research Consortium start phase II AT-7519 trial
Read More
FDA advisory committee votes in favor of ezogabine
Read More
Labopharm launches Oleptro in U.S. for major depressive disorder
Read More
Mologen reports results for first half of 2010
Read More
PMX-60056 shows promise as heparin activity-reversing agent in phase Ib/II trial
Read More
PSI-7977 receives FDA fast track status for chronic HCV infection
Read More
FDA grants orphan status to becaplermin in osteochondritis dissecans
Read More
FDA warns of risk of aseptic meningitis associated with Lamictal use
Read More
European Commission grants orphan status to bosutinib in CML
Read More